The hyperactivation of the RAS/RAF/MEK/ERK signaling pathway (hereafter MAPK), which is assessed in the vast majority of melanomas as a result of genetic alterations in BRAF, RAS, or NF1 among others [17,18,19,20,21], contributes to the pro-survival phenotype of melanoma cells. The gene discussed is NF1; the disease is melanoma.